Author:
Simmons Shaunna R.,Herring Sydney E.,Tchalla Essi Y.I,Lenhard Alexsandra P.,Bhalla Manmeet,Bou Ghanem Elsa N.
Abstract
Abstract
Background
Streptococcus pneumoniae (pneumococcus) is a leading cause of pneumonia in older adults. Successful control of pneumococci requires robust pulmonary neutrophil influx early in infection. However, aging is associated with aberrant neutrophil recruitment and the mechanisms behind that are not understood. Here we explored how neutrophil recruitment following pneumococcal infection changes with age and the host pathways regulating this.
Results
Following pneumococcal infection there was a significant delay in early neutrophil recruitment to the lungs of aged mice. Neutrophils from aged mice showed defects in trans-endothelial migration in vitro compared to young controls. To understand the pathways involved, we examined immune modulatory extracellular adenosine (EAD) signaling, that is activated upon cellular damage. Signaling through the lower affinity A2A and A2B adenosine receptors had no effect on neutrophil recruitment to infected lungs. In contrast, inhibition of the high affinity A1 receptor in young mice blunted neutrophil recruitment to the lungs following infection. A1 receptor inhibition decreased expression of CXCR2 on circulating neutrophils, which is required for trans-endothelial migration. Indeed, A1 receptor signaling on neutrophils was required for their ability to migrate across endothelial cells in response to infection. Aging was not associated with defects in EAD production or receptor expression on neutrophils. However, agonism of A1 receptor in aged mice rescued the early defect in neutrophil migration to the lungs and improved control of bacterial burden.
Conclusions
This study suggests age-driven defects in EAD damage signaling can be targeted to rescue the delay in pulmonary neutrophil migration in response to bacterial pneumonia.
Funder
National Institutes of Health
Publisher
Springer Science and Business Media LLC
Reference72 articles.
1. WHO. Pneumococcal disease. World Health Organization. 2014.
2. Grudzinska FS, Brodlie M, Scholefield BR, Jackson T, Scott A, Thickett DR, et al. Neutrophils in community-acquired pneumonia: parallels in dysfunction at the extremes of age. Thorax. 2020;75(2):164–71.
3. Simell B, Vuorela A, Ekstrom N, Palmu A, Reunanen A, Meri S, et al. Aging reduces the functionality of anti-pneumococcal antibodies and the killing of Streptococcus pneumoniae by neutrophil phagocytosis. Vaccine. 2011;29(10):1929–34.
4. Gonçalves MT, Mitchell TJ, Lord JM. Immune ageing and susceptibility to Streptococcus pneumoniae. Biogerontology. 2016;17(3):449–65.
5. CDC. Pneumococcal Disease Global Pneumococcal Disease and Vaccine CDC. Centers for Disease Control and Prevention; 2018 [updated 2018, November 15. https://www.cdc.gov/pneumococcal/global.html